Kayne Anderson Rudnick Investment Management LLC Sage Therapeutics, Inc. Transaction History

Kayne Anderson Rudnick Investment Management LLC

$42 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$27.52 - $37.99 $550 - $759	-20 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $614 - $914	20 New	20 $1,000

Others Institutions Holding SAGE

# of Institutions

220

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

Vanguard Group Inc Valley Forge, PA

5.75M
Shares

$70.7 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.48M
Shares

$67.4 Million
1.65% of portfolio
Black Rock Inc. New York, NY

4.89M
Shares

$60.1 Million
0.0% of portfolio
Wellington Management Group LLP Boston, MA

4.75M
Shares

$58.4 Million
0.02% of portfolio
State Street Corp Boston, MA

4.49M
Shares

$55.2 Million
0.0% of portfolio

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $730M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account